Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Wellness program for promoting healthy aging

Official title: First Line Prevent Age Study

Run by Prevent Age Resort "Pervaya Liniya" · NCT05361343 · Data updated 2026-11-12

This study is testing a wellness program that includes exercise, diet, and mental health support to see if it helps older adults stay healthy and active as they age.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorPrevent Age Resort "Pervaya Liniya"
Academic / other
Locations1 site (Saint Petersburg)
StatusRecruiting
StartedFebruary 2025
Main results expectedAugust 2026
Study endsSeptember 2026
Registry record updatedNovember 7, 2024
Trial IDNCT05361343 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy men and women over 18 years old who are interested in active longevity and willing to engage in lifestyle interventions.

Probably not a fit

Patients with significant comorbidities, severe mental illness, or those who do not adhere to lifestyle changes may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of a comprehensive wellness program designed to promote active longevity. The program includes motivational counseling, high-intensity training, intermittent fasting, hypoxic training, and strategies for improving sleep and mental well-being. It is a single-center, prospective, open-label study with a focus on maintaining health in older adults. Participants will be enrolled sequentially, and the outcomes will be assessed through blinded endpoint analysis.

Why it matters

Potential benefit: If successful, this program could significantly enhance the quality of life and longevity for participants by promoting healthier lifestyle choices.

How similar studies have gone: While similar wellness programs have shown promise in promoting healthy aging, this specific approach is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women over 18;
* No significant (affecting the functional state) "active" diseases: acute diseases and exacerbations of chronic diseases;
* Interest in active longevity and willingness to participate in research.
* Signed informed consent.

Exclusion Criteria:

* Age up to 18 years;
* Severe or moderate comorbidities;
* Rheumatological (systemic / autoimmune) diseases of any severity;
* Intestinal infections (within 3 months);
* SARS / pneumonia, other diseases accompanied by systemic inflammation during the last 2 months;
* Chronic inflammatory bowel disease;
* Major surgery within the last 3 months
* Intoxication (alcohol, drugs, other toxins);
* Oncological disease (except for basalioma) out of remission;
* Persons with mental illness;
* Diabetes;
* Syndrome of obstructive sleep apnea of moderate and severe severity;
* Low adherence to lifestyle interventions, including physical activity of less than 150 minutes of aerobic activity per week (at least two days per week) or 75 minutes of vigorous exercise (at least 3 days per week).

Where it's running

  • First Line Health Care Resort
    Saint Petersburg, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.